31 Mar 2023
Assets29.75
Total Income36.42
EBITDA3.28
Profit After Tax1.88
NET Worth1.01
Reserves and Surplus0.51
Total Borrowing16.19
At a glance
Updated 2026-08-24The shares listed at ₹146.10, a 14.14% move from the issue price. Curis Lifesciences is a SME IPO with an issue size of ₹27.52 crore, proposed for listing on NSE SME. The offer opens on 7th Nov 2025 and closes on 11th Nov 2025. The issue structure includes a fresh issue of ₹26.14 crore. The current listing schedule points to 14th Nov 2025.
Issue details
Listing atNSE SME
Issue typeBook Build Issue
Issue size₹27.52 Cr
Fresh issue₹26.14 Cr
Face value₹10
Price band₹120.00–₹128.00
Allotment12th Nov 2025
Listing14th Nov 2025
Listing performance
Full performance ↗Issue price₹128.00
Listing price₹146.10
Current price—
Listing gain14.14%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹9.00
GMP / upper price7.03%
Est. listing₹137.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens7th Nov 2025
Closes11th Nov 2025
Allotment12th Nov 2025
Refund13th Nov 2025
Demat13th Nov 2025
Listing14th Nov 2025
Subscription demand
Full bidding ↗Total74.39×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 2000 | ₹256,000 |
Company
Incorporated2010
Use of proceeds
| Object | Amount |
|---|---|
| Capital Expenditure towards Upgradation/Improvement of the existing Manufacturing Facilities | ₹2.44 Cr |
| Capital Expenditure towards Construction of a Storage Facility | ₹3.62 Cr |
| Pre-payment/Repayment of outstanding Secured Loans | ₹1.86 Cr |
| Product Registrations in other countries | ₹2.69 Cr |
| Funding working capital requirements | ₹11.25 Cr |
| General Corporate Purposes | ₹2.85 Cr |
| Issue Expenses | ₹2.80 Cr |
| Total | ₹27.52 Cr |
Financials
Full financials ↗31 Mar 2024
Assets33.88
Total Income35.87
EBITDA8.39
Profit After Tax4.87
NET Worth5.87
Reserves and Surplus5.37
Total Borrowing17.09
31 Mar 2025
Assets42.53
Total Income49.65
EBITDA9.54
Profit After Tax6.11
NET Worth16.23
Reserves and Surplus10.29
Total Borrowing15.62
31 Jul 2025
Assets56.29
Total Income19.51
EBITDA4.24
Profit After Tax2.87
NET Worth19.10
Reserves and Surplus13.16
Total Borrowing15.32
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 55.25% |
| ROCE | 27.83% |
| Debt / Equity | 0.96% |
| RoNW | 37.62% |
| PAT Margin | 12.43% |
| EBITDA Margin | 19.41% |
| Price to Book Value | 12.64 |
Valuation & shareholding
Pre-IPO EPS10.29
Post-IPO EPS10.66
Pre-IPO P/E12.44
Post-IPO P/E12.01
Promoter holding pre92.68%
Promoter holding post68.03%
Market cap₹103.48 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Capital Expenditure towards Upgradation/Improvement of the existing Manufacturing Facilities | ₹2.44 Cr |
| Capital Expenditure towards Construction of a Storage Facility | ₹3.62 Cr |
| Pre-payment/Repayment of outstanding Secured Loans | ₹1.86 Cr |
| Product Registrations in other countries | ₹2.69 Cr |
| Funding working capital requirements | ₹11.25 Cr |
| General Corporate Purposes | ₹2.85 Cr |
| Issue Expenses | ₹2.80 Cr |
| Total | ₹27.52 Cr |
Registrar & lead managers
Registrar
MUFG Intime India Pvt.Ltd.Lead managers
- Finaax Capital Advisors Pvt.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.